Rtw Investments as of March 31, 2020
Portfolio Holdings for Rtw Investments
Rtw Investments holds 65 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Rocket Pharmaceuticals (RCKT) | 10.1 | $235M | 17M | 13.95 | |
Alnylam Pharmaceuticals (ALNY) | 7.9 | $183M | 1.7M | 108.85 | |
Ptc Therapeutics I (PTCT) | 7.6 | $175M | 3.9M | 44.61 | |
Dicerna Pharmaceuticals | 5.5 | $128M | 7.0M | 18.37 | |
Bristol Myers Squibb (BMY) | 4.0 | $94M | 1.7M | 55.74 | |
Stoke Therapeutics (STOK) | 3.5 | $81M | 3.5M | 22.90 | |
Mirati Therapeutics | 3.3 | $76M | 985k | 76.87 | |
Homology Medicines | 2.9 | $68M | 4.4M | 15.54 | |
Zimmer Holdings (ZBH) | 2.9 | $68M | 672k | 101.08 | |
Masimo Corporation (MASI) | 2.9 | $68M | 383k | 177.12 | |
Immunovant (IMVT) | 2.8 | $66M | 4.4M | 14.88 | |
Adverum Biotechnologies | 2.8 | $65M | 6.6M | 9.77 | |
Axsome Therapeutics (AXSM) | 2.7 | $62M | 1.1M | 58.83 | |
Bellus Health | 2.4 | $55M | 5.5M | 9.97 | |
Sarepta Therapeutics (SRPT) | 2.2 | $52M | 529k | 97.82 | |
Axonics Modulation Technolog (AXNX) | 1.9 | $43M | 1.7M | 25.41 | |
Vericel (VCEL) | 1.8 | $41M | 4.5M | 9.17 | |
Natera (NTRA) | 1.6 | $38M | 1.3M | 29.86 | |
Frequency Therapeutics | 1.6 | $37M | 2.1M | 17.81 | |
Translate Bio | 1.6 | $37M | 3.7M | 9.97 | |
Global Blood Therapeutics In | 1.6 | $37M | 720k | 51.09 | |
Myokardia | 1.6 | $37M | 781k | 46.88 | |
Flamel Technologies Sa | 1.6 | $36M | 4.6M | 7.85 | |
Oyster Point Pharma | 1.5 | $34M | 970k | 35.00 | |
Relmada Therapeutics (RLMD) | 1.4 | $34M | 985k | 34.11 | |
Establishment Labs Holdings Ord (ESTA) | 1.4 | $34M | 2.3M | 14.45 | |
Agenus | 1.4 | $32M | 13M | 2.45 | |
Wave Life Sciences (WVE) | 1.4 | $32M | 3.4M | 9.37 | |
Dermtech Ord ord (DMTKQ) | 1.3 | $29M | 2.6M | 11.18 | |
Tandem Diabetes Care (TNDM) | 1.2 | $29M | 444k | 64.35 | |
Proqr Thrapeutics N V shs euro (PRQR) | 1.1 | $26M | 4.8M | 5.49 | |
Nanostring Technologies (NSTGQ) | 1.1 | $26M | 1.1M | 24.05 | |
STAAR Surgical Company (STAA) | 0.9 | $22M | 676k | 32.26 | |
Castle Biosciences (CSTL) | 0.9 | $21M | 698k | 29.81 | |
Exagen (XGN) | 0.9 | $20M | 1.3M | 15.94 | |
Protagonist Therapeutics (PTGX) | 0.8 | $19M | 2.7M | 7.06 | |
Johnson & Johnson (JNJ) | 0.7 | $15M | 117k | 131.13 | |
Arvinas Ord (ARVN) | 0.6 | $14M | 345k | 40.30 | |
Apyx Medical Corporation (APYX) | 0.5 | $12M | 3.4M | 3.59 | |
10x Genomics Inc Cl A (TXG) | 0.5 | $12M | 190k | 62.32 | |
Regenxbio Inc equity us cm (RGNX) | 0.4 | $10M | 314k | 32.38 | |
Odonate Therapeutics Ord | 0.4 | $10M | 366k | 27.61 | |
La Jolla Pharmaceuticl Com Par | 0.4 | $9.9M | 2.4M | 4.20 | |
MiMedx (MDXG) | 0.4 | $9.4M | 2.7M | 3.49 | |
Tela Bio (TELA) | 0.4 | $8.9M | 1.1M | 7.82 | |
Brainsway Ltd- (BWAY) | 0.4 | $8.8M | 1.1M | 7.94 | |
Cytomx Therapeutics (CTMX) | 0.4 | $8.2M | 1.1M | 7.67 | |
Milestone Pharmaceuticals (MIST) | 0.3 | $7.9M | 4.3M | 1.84 | |
Uniqure Nv (QURE) | 0.3 | $7.4M | 156k | 47.45 | |
Arbutus Biopharma (ABUS) | 0.3 | $6.9M | 6.9M | 1.01 | |
Clearside Biomedical (CLSD) | 0.3 | $6.6M | 3.9M | 1.70 | |
Transmedics Group (TMDX) | 0.3 | $6.1M | 503k | 12.08 | |
Itamar Med | 0.2 | $5.4M | 457k | 11.78 | |
Inmode Ltd. Inmd (INMD) | 0.2 | $5.4M | 250k | 21.50 | |
Lifesci Acquisition Corp unit 03/31/2025 | 0.2 | $5.0M | 500k | 10.00 | |
Chardan Healthcare Acqu- Ord (PHGE) | 0.2 | $4.2M | 600k | 7.00 | |
Argenx Se (ARGX) | 0.2 | $4.2M | 32k | 131.74 | |
Vivus Inc conv | 0.1 | $3.0M | 4.0M | 0.74 | |
Personalis Ord (PSNL) | 0.1 | $2.1M | 255k | 8.07 | |
Profound Med Corp (PROF) | 0.1 | $1.7M | 174k | 9.74 | |
Fulgent Genetics (FLGT) | 0.0 | $807k | 75k | 10.76 | |
Motus Gi Hldgs Incorporated | 0.0 | $523k | 776k | 0.67 | |
Twist Bioscience Corp (TWST) | 0.0 | $469k | 15k | 30.61 | |
Viewray (VRAYQ) | 0.0 | $375k | 150k | 2.50 | |
Chardan Healthcare Acq warrants (PHGEW) | 0.0 | $360k | 600k | 0.60 |